Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm trial of deferasirox in pediatric patients with transfusion-dependent rare inherited hemolytic anemia
TCTR20240612005Phase 3Recruiting
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deferasirox in iron overload, Hemolytic anemia (HA), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Apr 2023; status: recruiting.
02
Drugs
deferasirox
03
Conditions
iron overloadHemolytic anemia (HA)
Beyond the preview
Go deeper on TCTR20240612005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240612005.